Exact Sciences shareholders approve acquisition by Abbott
Source: SeekingAlpha
2026-02-20 16:17:26 ET
More on Exact Sciences
- Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics
- Exact Sciences ticks higher amid reports HSR for Abbott deal expired
- CyberArk/Palo Alto Networks, Dayforce/Thoma Bravo among good bets for deal close
- Seeking Alpha’s Quant Rating on Exact Sciences
- Historical earnings data for Exact Sciences
Read the full article on Seeking Alpha
For further details see:
Exact Sciences shareholders approve acquisition by Abbott
Exact Sciences Corporation
NASDAQ: EXAS
EXAS Trading
-0.06% G/L:
$103.14 Last:
1,448,280 Volume:
$103.27 Open:
EXAS Latest News
February 25, 2026 09:40:00 am
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
February 13, 2026 04:05:00 pm
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
EXAS Stock Data
$19,584,719,665
187,197,642
0.09%
291
N/A
Medical Diagnostics & Screening
Healthcare
US
Madison
